Back
M
Marie‐Kristin Tilch
Johannes Gutenberg University of Mainz
4H-index
13Paper Count
31Citation Count
Published Papers 2
Publication Date
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
BMC Cancer
IF3.4

